Deauville Criteria

Short description: Medical test used to assess lymphoma

This article needs more medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed.
Find sources: "Deauville Criteria" – news · newspapers · books · scholar · JSTOR (November 2021)

|
|

The Deauville 5-point scoring system is an internationally accepted and utilized five-point scoring system for the fluorodeoxyglucose (FDG) avidity of a Hodgkin lymphoma or Non-Hodgkin lymphoma tumor mass as seen on FDG positron emission tomography:[1]

* Score 1: No uptake above the background
* Score 2: Uptake ≤ mediastinum
* Score 3: Uptake > mediastinum but ≤ liver
* Score 4: Uptake moderately increased compared to the liver at any site
* Score 5: Uptake markedly increased compared to the liver at any site
* Score X: New areas of uptake unlikely to be related to lymphoma

Scores of 1 and 2 are considered to be negative and 4 and 5 are considered to be positive. "Score 3 should be interpreted according to the clinical context but in many Hodgkin Lymphoma patients indicates a good prognosis with standard treatment." [2]

## History

Deauville score was developed at Guy's and Saint Thomas Hospital in London after an international meeting at Deauville, France in 2009.

## References

1. ↑ Barrington et al., Eur J Nucl Med Mol Imaging (2010) 37:1824–1833
2. ↑ Follows et al, British Journal of Haematology, 2014, 166, 34–49.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Deauville Criteria. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Deauville_Criteria&oldid=4017958"